Business · 14/11/20261 min read
Innovative Immunology Biotech Windward Bio Lists on Nasdaq
Summary
SHANGHAI, Nov. 14, 2026 — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50...